- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 10.82M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $4K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$363K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.87M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.32M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $14.34M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.53M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $15.21M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $27.04M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $30.02M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.46M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.13M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.67M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $14.36M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $21.17M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $28.52M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $22.2M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $29.57M |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.69 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.52 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.92M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $3.35M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.13M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.9M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.21M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.34M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $10K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $50K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $8K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $13K |
| Revenue | Q1 2026 · Mar 31, 2026 | $18K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $63K |